FINWIRES · TerminalLIVE
FINWIRES

Enduro Metals Upsizes a Private Placement of Share Units to $7.8 Million

作者

-- Enduro Metals (ENDR.V) on Thursday said it is upsizing a "best efforts" private placement to $7.8 million from $5 million.

The offering will now consist of the sale of 9.4-million non-flow-through units (NFT units) priced at $0.16 each and made up of a share and one half of a three-year warrant to buy a share for $0.24.

It will also place up to 28.6-million charity flow-through units for $0.22 each and made up of a tax-advantaged share and one half of a warrant with the same terms.

The company will concurrently place up to 6.6-million NFT units at $0.16 apiece for up to $1.1 million on a private placement basis "pursuant to other applicable exemptions from the prospectus requirements under Canadian securities laws".

Proceeds from the sale of NFT units and the concurrent private placement will be used for exploration and development at its mineral projects and for working capital and general corporate needs.

Shares of the company were last seen down $0.01 at $0.165 on the TSX Venture Exchange.

Price: $0.17, Change: $-0.01, Percent Change: -5.71%

相关文章

Research

国民银行维持对Capstone的“优于大盘”评级,但将目标价从15加元下调至14加元,理由是“目标价小幅下调是考虑到硫酸成本压力”。

Price: $11.22, Change: $+0.38, Percent Change: +3.51%

$CS.TO
Research

研究快讯:CFRA维持对默克公司股票的买入评级,此前该公司发布了第一季度财报。

独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们维持目标价135美元,相当于2027年每股收益预期值的13.4倍,低于默克公司过去10年的平均预期市盈率。我们维持2026年每股收益预期5.14美元,2027年每股收益预期10.06美元。默克公司公布了2026年第一季度稳健的业绩,其营收增长强劲,产品线和产品组合转型也取得了显著进展。由于肿瘤和动物保健部门的持续强劲表现,以及新产品上市带来的贡献不断增长,总营收达到163亿美元(同比增长5%)。该公司正积极执行一项成功的战略,即通过内部和外部研发,实现其增长动力来源的多元化,使其不再仅仅依赖于旗舰药物 KEYTRUDA。我们认为,预计将于第二季度完成的 Terns 收购案,将凭借其用于治疗慢性粒细胞白血病的 TERN-701 进一步增强 MRK 的血液学产品线,这也体现了该公司在战略转型过程中持续推进的外部创新举措。

$MRK
Australia

Leerink Partners 将 Labcorp 的目标股价从 347 美元下调至 340 美元。

根据FactSet调查的分析师报告,Labcorp (LH) 的平均评级为“增持”,平均目标价为311.35美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $257.19, Change: $+0.05, Percent Change: +0.02%

$LH